文献速递消化道肿瘤与早癌消化内镜

亚洲国家的内镜筛查与胃癌死亡率降低相关:一项荟萃分析与系统综述

Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review.
PubMed 文献 · Gastroenterology · 2018-04-30

该系统综述与荟萃分析纳入6项队列研究和4项巢式病例对照研究、共342,013名来自亚洲的成人,评估内镜筛查与胃癌死亡率及发病率的关系。合并结果显示内镜筛查与胃癌死亡率降低40%相关(RR 0.60,95%CI 0.49-0.73),但与发病率无显著关联(RR 1.14,95%CI 0.93-1.40)。

要点

  • 内镜筛查与胃癌死亡率降低40%相关(RR 0.60,95%CI 0.49-0.73)。
  • 内镜筛查与胃癌发病率无显著关联(RR 1.14,95%CI 0.93-1.40)。
  • 与放射线筛查相比,内镜筛查与胃癌死亡率显著降低相关(RR 0.33,95%CI 0.12-0.91)。

核心结论

  • 在亚洲国家,内镜筛查可能降低胃癌死亡风险,且不影响发病率。
  • 作者认为需开展基于人群的前瞻性队列研究以证实上述发现。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed和EMBASE截至2018年3月8日发表的队列研究和病例对照研究。
  • 纳入至少接受过一次内镜筛查、无胃癌的成人,设有对照并报告死亡率或发病率结局的研究。
  • 最终纳入6项队列研究和4项巢式病例对照研究,共342,013名个体,全部来自亚洲。
  • 采用随机效应模型合并相对风险(RR)及其95%置信区间(CI)。

主要发现

  • 内镜筛查与胃癌死亡率降低40%相关(RR 0.60,95%CI 0.49-0.73)。
  • 内镜筛查与胃癌发病率无显著关联(RR 1.14,95%CI 0.93-1.40)。
  • 与无筛查相比,内镜筛查与胃癌死亡率显著降低相关(RR 0.58,95%CI 0.48-0.70)。
  • 与放射线筛查相比,内镜筛查与胃癌死亡率显著降低相关(RR 0.33,95%CI 0.12-0.91)。
  • 与预期死亡数相比,内镜筛查未显著降低死亡率(RR 0.67,95%CI 0.38-1.16)。

临床怎么用

  • 原文结论指出内镜筛查可能降低亚洲国家胃癌死亡风险且不影响发病率,作者认为需前瞻性队列研究证实。

局限性

  • 作者认为需开展基于人群的前瞻性队列研究以证实本研究发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: It is not clear how endoscopic screening for gastric cancer affects incidence or mortality. We performed a systematic review and meta-analysis to evaluate the relationship between endoscopic screening for gastric cancer and mortality and incidence. METHODS: We conducted a systematic search of PubMed and EMBASE for published cohort and case-control studies of adults without gastric cancer who underwent endoscopic screening at least once that included a comparator and reported outcomes of mortality or incidence through March 8, 2018. Two investigators independently reviewed the included studies and extracted relevant data. The effect estimate of interest was the relative risk (RR). We used a random effects model to combine RRs and 95% confidence intervals (Cis). RESULTS: Our final analysis included 6 cohort studies and 4 nested case-control studies comprising 342,013 individuals, all from Asia. The combined result (RR, 0.60; 95% CI, 0.49-0.73) indicated that endoscopic screening was associated with a 40% RR reduction in gastric cancer mortality. We did not observe an association between endoscopic screening and incidence (RR, 1.14; 95% CI, 0.93-1.40). Subgroup analysis showed significant reductions in gastric cancer mortality after endoscopic screening compared with no screening (RR, 0.58; 95% CI, 0.48-0.70) or radiographic screening (RR, 0.33; 95% CI, 0.12-0.91). However, endoscopic screening did not significantly reduce mortality compared with expected deaths (RR, 0.67; 95% CI, 0.38-1.16). CONCLUSIONS: In a systematic review and meta-analysis, we found that endoscopic screening may reduce the risk of death from gastric cancer and not affect incidence in Asian countries. Population-based prospective cohort studies are warranted to confirm our findings.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Zhang X, Li M, Chen S, et al. Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review. Gastroenterology. 2018. PMID: 29723507. doi:10.1053/j.gastro.2018.04.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。